Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol®) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer

This publication has 13 references indexed in Scilit:

• Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
  Journal of Clinical Oncology, 1998
• A phase I/II study of paclitaxel (Taxol®) and concurrent radiotherapy in advanced nonsmall cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Lung fibrosis induced by paclitaxel.
  Supportive Care in Cancer, 1997
• Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
  Radiotherapy and Oncology, 1997
• Paclitaxel as a radiosensitiser: A proposed schedule of administration based on in vitro data and pharmacokinetic calculations
  European Journal Of Cancer, 1997
• Dose escalation for non-small cell lung cancer using conformal radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.
  Journal of Clinical Oncology, 1994
• Taxol: A novel radiation sensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The biological basis for conformal three-dimensional radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group
  Cancer, 1987